Study of an experimental drug for kidney disease from type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are treating it with medicine, diet, or lifestyle changes.
- Your blood sugar level (A1C) is between 6.5% and 10%.
- Your kidney function is moderately reduced (based on a standard blood test).
- You have protein in your urine, which is a sign of kidney damage.
- You have not needed dialysis or a kidney transplant, and you do not have kidney disease that is not caused by diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a goal-directed treatment plan using several medications can lower the risk of kidney and heart problems for people with diabetes and kidney disease. It aims to help you manage your condition more effectively.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This trial tests whether a new drug, HTD1801, can protect or improve kidney function in people with type 2 diabetes and chronic kidney disease. It may help slow kidney damage and reduce protein in urine.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
This trial tests a new oral medication (DWP16001) for people with type 2 diabetes who also have moderate kidney problems. It aims to see if the drug is safe and helps control blood sugar while protecting kidney function.
Hear when a new Diabetic Kidney Disease (DKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.